JP2014521089A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2014521089A5 JP2014521089A5 JP2014520229A JP2014520229A JP2014521089A5 JP 2014521089 A5 JP2014521089 A5 JP 2014521089A5 JP 2014520229 A JP2014520229 A JP 2014520229A JP 2014520229 A JP2014520229 A JP 2014520229A JP 2014521089 A5 JP2014521089 A5 JP 2014521089A5
- Authority
- JP
- Japan
- Prior art keywords
- ndpoi
- antibody
- bead
- complex
- capture antibody
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000000034 method Methods 0.000 claims 16
- 239000011324 bead Substances 0.000 claims 15
- 238000001514 detection method Methods 0.000 claims 10
- 239000012472 biological sample Substances 0.000 claims 8
- 230000001225 therapeutic effect Effects 0.000 claims 5
- 210000002569 neuron Anatomy 0.000 claims 4
- 102000004169 proteins and genes Human genes 0.000 claims 4
- 108090000623 proteins and genes Proteins 0.000 claims 4
- 208000024827 Alzheimer disease Diseases 0.000 claims 3
- 241000124008 Mammalia Species 0.000 claims 3
- 239000011859 microparticle Substances 0.000 claims 3
- 230000005298 paramagnetic effect Effects 0.000 claims 3
- 239000003814 drug Substances 0.000 claims 1
- 230000000694 effects Effects 0.000 claims 1
- 229940124597 therapeutic agent Drugs 0.000 claims 1
- 238000002560 therapeutic procedure Methods 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201161507332P | 2011-07-13 | 2011-07-13 | |
| US61/507,332 | 2011-07-13 | ||
| PCT/US2012/045886 WO2013009667A1 (en) | 2011-07-13 | 2012-07-09 | Method for detection of amyloid beta oligomers in a fluid sample and uses thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2014521089A JP2014521089A (ja) | 2014-08-25 |
| JP2014521089A5 true JP2014521089A5 (enExample) | 2015-08-27 |
Family
ID=47506433
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014520229A Pending JP2014521089A (ja) | 2011-07-13 | 2012-07-09 | 液体試料中のアミロイドベータオリゴマーの検出方法およびその使用 |
Country Status (13)
| Country | Link |
|---|---|
| US (2) | US20130052670A1 (enExample) |
| EP (2) | EP2732289B1 (enExample) |
| JP (1) | JP2014521089A (enExample) |
| KR (1) | KR20140072019A (enExample) |
| CN (1) | CN103782171B (enExample) |
| AU (1) | AU2012282825B2 (enExample) |
| BR (1) | BR112014000671A2 (enExample) |
| CA (1) | CA2840976A1 (enExample) |
| DK (1) | DK2732289T3 (enExample) |
| ES (1) | ES2666840T3 (enExample) |
| MX (1) | MX2014000480A (enExample) |
| RU (1) | RU2014105172A (enExample) |
| WO (2) | WO2013009703A2 (enExample) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PL3449926T3 (pl) | 2009-06-17 | 2020-06-01 | Biogen Ma Inc. | Kompozycje i sposoby modulacji składania smn2 u pacjenta |
| US9320793B2 (en) * | 2010-07-14 | 2016-04-26 | Acumen Pharmaceuticals, Inc. | Method for treating a disease associated with soluble, oligomeric species of amyloid beta 1-42 |
| EP2943225A4 (en) | 2013-01-09 | 2016-07-13 | Ionis Pharmaceuticals Inc | COMPOSITIONS AND METHODS FOR MODULATING SMN2 DISTRIBUTION IN THE BODY OF A PATIENT |
| CA2931220A1 (en) * | 2013-11-20 | 2015-05-28 | University Of Iowa Research Foundation | Methods and compositions for treating amyloid deposits |
| MA39835A (fr) | 2014-04-17 | 2017-02-22 | Biogen Ma Inc | Compositions et procédés de modulation de l'épissage du smn2 chez un patient |
| WO2015175769A1 (en) | 2014-05-15 | 2015-11-19 | Biogen Ma Inc. | Methods for the detection of amyloid beta oligomers in biological samples |
| US10436802B2 (en) | 2014-09-12 | 2019-10-08 | Biogen Ma Inc. | Methods for treating spinal muscular atrophy |
| MA41480A (fr) * | 2014-10-17 | 2017-12-19 | Glenmark Pharmaceuticals Sa | Anticorps qui se lient au ccr6 et leurs utilisations |
| DK3341725T3 (da) * | 2015-08-25 | 2021-09-06 | Prothena Biosciences Ltd | Fremgangsmåder til detektering af phosphoryleret alpha-synuklein |
| WO2017138497A1 (ja) | 2016-02-08 | 2017-08-17 | シスメックス株式会社 | 被検物質の検出方法および被検物質の検出用試薬キット |
| EP3471779A4 (en) | 2016-06-16 | 2020-07-08 | Ionis Pharmaceuticals, Inc. | COMBINATIONS FOR MODULATING SMN EXPRESSION |
| US20220268789A1 (en) * | 2019-07-05 | 2022-08-25 | Shimadzu Corporation | Monoclonal antibody against amyloid beta, and method for measuring amyloid beta-related peptide using said antibody |
| PH12022552258A1 (en) | 2020-02-28 | 2023-11-20 | Ionis Pharmaceuticals Inc | Compounds and methods for modulating smn2 |
| KR102798206B1 (ko) * | 2021-06-25 | 2025-04-22 | 장재원 | 동적 형광 또는 x-선의 표준편차와 자기상관을 활용한 조기 진단 시스템 |
| EP4399218A4 (en) * | 2021-08-30 | 2025-10-29 | Brigham & Womens Hospital Inc | METHODS AND MATERIALS FOR TREATING A NEURODEGENERATIVE DISEASE |
| EP4562427A2 (en) * | 2022-07-27 | 2025-06-04 | Durin Life Sciences, Inc. | Early detection and monitoring of neurodegenerative diseases using a multi-disease diagnostic platform |
| CN117589996A (zh) * | 2022-08-09 | 2024-02-23 | 深圳智源生物医药有限公司 | 强毒性淀粉样蛋白寡聚体的诊断用途 |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4665024A (en) | 1984-10-01 | 1987-05-12 | Becton, Dickinson And Company | Fluorescent gram stain |
| US6218506B1 (en) | 1997-02-05 | 2001-04-17 | Northwestern University | Amyloid β protein (globular assembly and uses thereof) |
| US6082205A (en) | 1998-02-06 | 2000-07-04 | Ohio State University | System and device for determining particle characteristics |
| CA2381323C (en) | 1999-08-04 | 2009-10-06 | University Of Southern California | Amyloid .beta. protein (globular assembly and uses thereof) |
| CN1871517A (zh) * | 2002-02-19 | 2006-11-29 | 免疫公司 | 快速有效分离循环癌细胞的方法和试剂 |
| US7807157B2 (en) | 2004-02-20 | 2010-10-05 | Intellect Neurosciences Inc. | Monoclonal antibodies and use thereof |
| EP1743170A2 (en) * | 2004-04-02 | 2007-01-17 | Merck & Co., Inc. | Methods for detecting substances which bind to the amyloid precursor protein or beta amyloid fragments, and binding compounds |
| US7572640B2 (en) | 2004-09-28 | 2009-08-11 | Singulex, Inc. | Method for highly sensitive detection of single protein molecules labeled with fluorescent moieties |
| JP5173426B2 (ja) | 2004-10-25 | 2013-04-03 | メルク・シャープ・エンド・ドーム・コーポレイション | 抗ａｄｄｌ抗体およびこの使用 |
| US7731962B2 (en) | 2005-02-14 | 2010-06-08 | Merck & Co., Inc. | Anti-ADDL monoclonal antibody and use thereof |
| JP5289963B2 (ja) * | 2005-10-21 | 2013-09-11 | メルク・シャープ・アンド・ドーム・コーポレーション | 抗ａｄｄｌモノクローナル抗体およびその使用 |
| US20090181359A1 (en) * | 2007-10-25 | 2009-07-16 | Lou Sheng C | Method of performing ultra-sensitive immunoassays |
| CA2779565A1 (en) * | 2009-11-24 | 2011-06-03 | Probiodrug Ag | Novel diagnostic method for the diagnosis of alzheimer's disease or mild cognitive impairment |
| EP2576617B1 (en) * | 2010-06-04 | 2016-04-27 | Georg-August-Universität Göttingen Stiftung Öffentlichen Rechts Universitätsmedizin | MONOCLONAL ANTIBODIES TARGETING Aß OLIGOMERS |
| US9320793B2 (en) * | 2010-07-14 | 2016-04-26 | Acumen Pharmaceuticals, Inc. | Method for treating a disease associated with soluble, oligomeric species of amyloid beta 1-42 |
| AU2011279221B2 (en) * | 2010-07-14 | 2015-06-11 | Merck Sharp & Dohme Corp. | Anti-ADDL monoclonal antibody and uses thereof |
-
2012
- 2012-07-09 WO PCT/US2012/045956 patent/WO2013009703A2/en not_active Ceased
- 2012-07-09 BR BR112014000671A patent/BR112014000671A2/pt not_active IP Right Cessation
- 2012-07-09 JP JP2014520229A patent/JP2014521089A/ja active Pending
- 2012-07-09 AU AU2012282825A patent/AU2012282825B2/en active Active
- 2012-07-09 US US13/544,554 patent/US20130052670A1/en not_active Abandoned
- 2012-07-09 CA CA2840976A patent/CA2840976A1/en not_active Abandoned
- 2012-07-09 WO PCT/US2012/045886 patent/WO2013009667A1/en not_active Ceased
- 2012-07-09 EP EP12737445.2A patent/EP2732289B1/en active Active
- 2012-07-09 CN CN201280044598.3A patent/CN103782171B/zh active Active
- 2012-07-09 KR KR1020147003386A patent/KR20140072019A/ko not_active Withdrawn
- 2012-07-09 ES ES12737445.2T patent/ES2666840T3/es active Active
- 2012-07-09 RU RU2014105172/15A patent/RU2014105172A/ru not_active Application Discontinuation
- 2012-07-09 EP EP12811245.5A patent/EP2732286A4/en not_active Withdrawn
- 2012-07-09 MX MX2014000480A patent/MX2014000480A/es not_active Application Discontinuation
- 2012-07-09 DK DK12737445.2T patent/DK2732289T3/en active
-
2013
- 2013-12-20 US US14/137,351 patent/US20140120037A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2014521089A5 (enExample) | ||
| RU2014105172A (ru) | Способ обнаружения олигомеров бета-амилоида в образце жидкости организма и варианты его применения | |
| JP2016513094A5 (enExample) | ||
| JP2010516678A5 (enExample) | ||
| JP2020521951A5 (enExample) | ||
| JP2017184729A5 (enExample) | ||
| JP2017524130A5 (enExample) | ||
| JP2020517919A5 (enExample) | ||
| Tang et al. | Quantum dots-based sandwich immunoassay for sensitive detection of Alzheimer's disease-related Aβ1–42 | |
| Higgins et al. | Systemic release of high mobility group box 1 (HMGB1) protein is associated with severe and fatal Plasmodium falciparum malaria | |
| JP2016500110A5 (enExample) | ||
| JP2013511735A5 (enExample) | ||
| JP2011516046A5 (enExample) | ||
| WO2014037588A3 (en) | Methods and compounds for preventing, treating and diagnosing an inflammatory condition | |
| JP2017522555A5 (enExample) | ||
| WO2012103324A3 (en) | Method for detection of intestinal, and blood-brain barrier permeability and testing materials thereto | |
| JP2014517308A5 (enExample) | ||
| Leng et al. | mTOR activation induces endolysosomal remodeling and nonclassical secretion of IL-32 via exosomes in inflammatory reactive astrocytes | |
| Li et al. | Artificial Intelligence‐Guided Gut‐Microenvironment‐Triggered Imaging Sensor Reveals Potential Indicators of Parkinson's Disease | |
| JP2015529633A5 (enExample) | ||
| JP2016526167A5 (enExample) | ||
| JP2021508044A (ja) | アルファ−シヌクレイン病のアッセイ、方法、及び治療 | |
| JP2016095233A (ja) | 早期肝細胞がん患者の再発リスクの予測を補助する方法、システム及びコンピュータプログラム製品 | |
| EA201490576A1 (ru) | Молекулярный маркер для ранней диагностики мезотелиомы плевры у пациентов и способы для анализа его экспрессии | |
| Nyawira Maranga et al. | IL‐6 is upregulated in late‐stage disease in monkeys experimentally infected with Trypanosoma brucei rhodesiense |